All SEC Filings :: Ligand Pharmaceuticals Incorporated (LGND)

Filter Filings:

Date	Form	Description	Docs	XBRL	Pages
11/14/00	10-Q	Quarterly report pursuant to Section 13 or 15(d) Related Documents EX-27.1			19
11/06/00	8-K	Current report filing Related Documents EX-1			3
10/10/00	SC 13G/A	Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions			2
09/11/00	SC 13D/A	Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities Related Documents EX-4			10
08/14/00	10-Q	Quarterly report pursuant to Section 13 or 15(d) Related Documents EX-10.224 EX-27.1			70
08/08/00	S-8	Initial registration statement for securities to be offered to employees pursuant to employee benefit plans Related Documents EX-5.1 EX-23.2 EX-99.1 EX-99.4			34
05/15/00	10-Q	Quarterly report pursuant to Section 13 or 15(d) Related Documents EX-2.3 EX-10.219 EX-10.220 EX-10.221 EX-10.222 EX-10.223 EX-27.1			162
04/19/00	DEF 14A	Definitive proxy statements			63
04/06/00	PRE 14A	Preliminary proxy statement not related to a contested matter or merger/acquisition			63
03/29/00	10-K	Annual report pursuant to Section 13 and 15(d) Related Documents EX-10.213 EX-10.214 EX-10.215 EX-10.216 EX-10.217 EX-10.218 EX-21.1 EX-23.1 EX-27.1			102